A Complete Response After Pseudo-progression: Pembrolizumab for Metastatic Squamous Cell Carcinoma (SCC) of the Bladder.
Publication
, Journal Article
Kao, C; McNamara, M; Alley, C; Spector, N; Jauhari, S; Gupta, RT; Zhang, T; Zhu, J
Published in: Clin Genitourin Cancer
June 2019
Duke Scholars
Published In
Clin Genitourin Cancer
DOI
EISSN
1938-0682
Publication Date
June 2019
Volume
17
Issue
3
Start / End Page
e672 / e677
Location
United States
Related Subject Headings
- Urinary Bladder Neoplasms
- Treatment Outcome
- Oncology & Carcinogenesis
- Neoplasm Metastasis
- Middle Aged
- Male
- Humans
- Carcinoma, Squamous Cell
- Antineoplastic Agents, Immunological
- Antibodies, Monoclonal, Humanized
Citation
APA
Chicago
ICMJE
MLA
NLM
Kao, C., McNamara, M., Alley, C., Spector, N., Jauhari, S., Gupta, R. T., … Zhu, J. (2019). A Complete Response After Pseudo-progression: Pembrolizumab for Metastatic Squamous Cell Carcinoma (SCC) of the Bladder. Clin Genitourin Cancer, 17(3), e672–e677. https://doi.org/10.1016/j.clgc.2019.03.019
Kao, Chester, Megan McNamara, Chris Alley, Neil Spector, Shekeab Jauhari, Rajan T. Gupta, Tian Zhang, and Jason Zhu. “A Complete Response After Pseudo-progression: Pembrolizumab for Metastatic Squamous Cell Carcinoma (SCC) of the Bladder.” Clin Genitourin Cancer 17, no. 3 (June 2019): e672–77. https://doi.org/10.1016/j.clgc.2019.03.019.
Kao C, McNamara M, Alley C, Spector N, Jauhari S, Gupta RT, et al. A Complete Response After Pseudo-progression: Pembrolizumab for Metastatic Squamous Cell Carcinoma (SCC) of the Bladder. Clin Genitourin Cancer. 2019 Jun;17(3):e672–7.
Kao, Chester, et al. “A Complete Response After Pseudo-progression: Pembrolizumab for Metastatic Squamous Cell Carcinoma (SCC) of the Bladder.” Clin Genitourin Cancer, vol. 17, no. 3, June 2019, pp. e672–77. Pubmed, doi:10.1016/j.clgc.2019.03.019.
Kao C, McNamara M, Alley C, Spector N, Jauhari S, Gupta RT, Zhang T, Zhu J. A Complete Response After Pseudo-progression: Pembrolizumab for Metastatic Squamous Cell Carcinoma (SCC) of the Bladder. Clin Genitourin Cancer. 2019 Jun;17(3):e672–e677.
Published In
Clin Genitourin Cancer
DOI
EISSN
1938-0682
Publication Date
June 2019
Volume
17
Issue
3
Start / End Page
e672 / e677
Location
United States
Related Subject Headings
- Urinary Bladder Neoplasms
- Treatment Outcome
- Oncology & Carcinogenesis
- Neoplasm Metastasis
- Middle Aged
- Male
- Humans
- Carcinoma, Squamous Cell
- Antineoplastic Agents, Immunological
- Antibodies, Monoclonal, Humanized